Correspondence on ''Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review''.
Martin
M
Bares
Eduard
E
Minks
Ivica
I
Husárová
Katerina
K
Ferencová
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use; D017060:Patient Satisfaction; D011788:Quality of Life; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A